Primary Malignant Fibrous Histiocytoma of Bone
Authors
Affiliations
A review of over 400 primary bone tumors yielded 11 lesions with features allowing classification as malignant fibrous histiocytoma on a purely histological basis. Correlation with roentgenograms and clinical data indicated that these tumors occurred as osteolytic lesions associated with a high incidence of pathologic fractures in the metaphyses of skeletally mature long bones. Nine patients developed pulmonary metastases and 3 developed lymph node metastases within 21 months following diagnosis. The average survival was 12 months in 6 of the 9 patients who had no secondary treatment in their metastases. Treatment of 3 patients with metastatic lesions with chemotherapy or radiotherapy has been clinically encouraging. Some evidence was obtained that either or both the histiocytic and fibroblastic component may metastasize. There is a need for biopsy of metastatic lesions and autopsy followup to more accurately assess the mode of spread and histologic type of the metastases.
Mankin H, Hornicek F, DeLaney T, Harmon D, Schiller A Musculoskelet Surg. 2012; 96(3):171-7.
PMID: 23129168 DOI: 10.1007/s12306-012-0225-0.
Kubica A, Rose P, Weaver A, Brewer J Mayo Clin Proc. 2011; 86(8):738-43.
PMID: 21803956 PMC: 3146374. DOI: 10.4065/mcp.2010.0720.
MFH of bone and osteosarcoma show similar survival and chemosensitivity.
Jeon D, Song W, Kong C, Kim J, Lee S Clin Orthop Relat Res. 2010; 469(2):584-90.
PMID: 20559764 PMC: 3018190. DOI: 10.1007/s11999-010-1428-z.
Cerebral metastases from malignant fibrous histiocytoma of bone.
Rogers S, Whelan J Sarcoma. 2008; 4(3):125-8.
PMID: 18521291 PMC: 2395436. DOI: 10.1080/13577140020008093.
de Smet A, Hafez G Skeletal Radiol. 1994; 23(5):388-91.
PMID: 7939841 DOI: 10.1007/BF02417000.